Roger Spencer has been the Chief Executive since December 2013.

Roger has managed significant Christie service developments including creation of a network of oncology (radiotherapy and chemotherapy) centres which have transformed delivery of services for the 3.2m population of Greater Manchester and Cheshire. He led the establishment of The Christie’s innovation partnerships with government, commercial, third sector and academic organisations. These include pathology, specialist diagnostic services, private patients (HCA Healthcare- The Christie Private Care) and an academic investment partnership.

In 2016 he led the Trust to a CQC Outstanding rating, repeated in 2018. In the same year, The Christie opened the UK’s first national proton service.

Roger led for Greater Manchester on the National Cancer Vanguard developing and testing new models of care.  He is the Chair of Greater Manchester Cancer Alliance GM Cancer and the Greater Manchester Clinical Research Network GM CRN and a member of the Manchester Cancer Research Centre Steering Board MCRC Governance, working with a comprehensive group of stakeholders to improve and develop leading edge cancer services. 

He is a member of the National Cancer Board of NHS England and chairs their Early Detection and Screening Task and Finish Group.

He is a member of Healthcare UK Panel of Advisors.​